Helius Medical Technologies, Inc. provided revenue guidance for the first quarter of 2022. For the period, the company expects revenue to range from $150,000 to $170,000 and quarterly revenue to increase sequentially each quarter throughout the year as the U.S. commercialization of PoNS develops.